Exercise testing, exercise training, respiratory disease, review
ALL Metrics
-
Views
Downloads
How to cite this article
Bowhay B, Williams CA, Gibbons MA et al. Exploring the potential of cardiopulmonary exercise testing (CPET) for tailored pulmonary rehabilitation in people with interstitial lung disease (ILD): A systematic review protocol [version 2; peer review: 2 approved, 1 approved with reservations]. NIHR Open Res 2025, 4:51 (https://doi.org/10.3310/nihropenres.13706.2) NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
Export Citation
Sciwheel
EndNote
Ref. Manager
Bibtex
ProCite
Sente
Select a format first
▬
✚
Study Protocol
Revised Exploring the potential of cardiopulmonary exercise testing (CPET) for tailored pulmonary rehabilitation in people with interstitial lung disease (ILD): A systematic review protocol
[version 2; peer review: 2 approved, 1 approved with reservations]
Previously titled: Exploring the potential of cardiopulmonary exercise testing (CPET) for individualised pulmonary rehabilitation in people with interstitial lung disease (ILD): A systematic review protocol
Ben Bowhay1-3, Craig A Williams2-4, Michael A Gibbons2,3, Chris J Scotton1-3, Owen W Tomlinson
https://orcid.org/0000-0003-4063-7682
1-3Ben Bowhay1-3, Craig A Williams2-4, [...] Michael A Gibbons2,3, Chris J Scotton1-3, Owen W Tomlinson
https://orcid.org/0000-0003-4063-7682
1-3 PUBLISHED 04 Jul 2025
Author details Author details
1 Clinical & Biomedical Sciences, University of Exeter, Exeter, England, UK
2 Academic Department of Respiratory Medicine, Royal Devon University Healthcare NHS Foundation Trust, Exeter, England, UK
3 NIHR Biomedical Research Centre, University of Exeter, Exeter, England, UK
4 Public Health & Sport Sciences, University of Exeter, Exeter, England, UK
2 Academic Department of Respiratory Medicine, Royal Devon University Healthcare NHS Foundation Trust, Exeter, England, UK
3 NIHR Biomedical Research Centre, University of Exeter, Exeter, England, UK
4 Public Health & Sport Sciences, University of Exeter, Exeter, England, UK
Ben Bowhay
Roles: Methodology, Writing – Original Draft Preparation, Writing – Review & Editing
Roles: Methodology, Writing – Original Draft Preparation, Writing – Review & Editing
Craig A Williams
Roles: Conceptualization, Methodology, Supervision, Writing – Review & Editing
Roles: Conceptualization, Methodology, Supervision, Writing – Review & Editing
Michael A Gibbons
Roles: Conceptualization, Methodology, Supervision, Writing – Review & Editing
Roles: Conceptualization, Methodology, Supervision, Writing – Review & Editing
Chris J Scotton
Roles: Conceptualization, Methodology, Supervision, Writing – Review & Editing
Roles: Conceptualization, Methodology, Supervision, Writing – Review & Editing
Owen W Tomlinson
Roles: Conceptualization, Methodology, Supervision, Writing – Review & Editing
Roles: Conceptualization, Methodology, Supervision, Writing – Review & Editing
OPEN PEER REVIEW
REVIEWER STATUS
This review aims to identify which cardiopulmonary exercise test (CPET) derived variables can be used to personalise pulmonary rehabilitation (PR) for people with interstitial lung diseases. A ‘one size fits all’ approach does not benefit every patient due to a multitude of unique characteristics, subsets and phenotypes. No ILD-specific, tailored pulmonary rehabilitation guidelines exist in this area and exercise programme development is lacking. This leads to wide variation in the success within the literature and clinical practice.
MEDLINE, Embase, CINAHL, SPORTDiscus and the Cochrane Database of Systematic Reviews will be searched to identify studies that utilise CPET variables for PR development. Quality assessment is to be performed using the Critical Appraisal Skills Program (CASP) checklists for single cohort studies and randomised controlled studies.
The primary outcomes found within the included studies for peak volume of oxygen consumption (VO2peak), work rate (WRpeak), oxygen consumption at anaerobic threshold (VO2-AT), heart rate and rate of perceived exertion (RPE) would help determine which variables are optimal for prescription success. Identification of reliable methods to tailor PR for people with interstitial lung disease would enhance what is already known and potentially lead to best practice guideline development.
In accordance with the guidelines, this systematic review protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO) on 07 May 2024 (registration number CRD42024543174).
Interstitial lung diseases (ILD) are a group of around 200 long-term lung conditions, which often lead to lung failure. Pulmonary Rehabilitation (PR) is a mix of exercise, advice and education that is used to support people with ILD (pwILD) to help maintain their lung function, general function, and quality of life.
However, a ‘one size fits all’ PR approach may not be best, due to the many challenges found for ILD as a condition. Therefore, using a gold-standard tool like Cardiopulmonary Exercise Testing (CPET) can help to assess these challenges; as we look to understand how the heart, lungs and muscle work during exercise for each pwILD and these outcomes would help support person-centred exercise selection.
The systematic review aims to discover which CPET outcomes can be used to tailor PR for people with ILD. A range of databases (MEDLINE, Embase, CINAHL, SPORTDiscus and the Cochrane Database of Systematic Reviews) will be searched to identify studies that meet this aim, and checklists (Critical Appraisal Skills Program, CASP) will then be used to rate the quality of the included studies.
No tailored PR guidelines are available for pwILD, which leads to many differences in the success of PR. We will review the current evidence, with the aim to see which CPET outcomes can be used for PR selection. The systematic review results would help to show if technically appropriate methods can be developed for tailored PR in pwILD and support the design of future studies that can guide PR practice.
Exercise testing, exercise training, respiratory disease, review
Corresponding Author(s)
Owen W Tomlinson (
[email protected])
Grant information: This project is funded by the National Institute for Health and Care Research (NIHR) Exeter Biomedical Research Centre (BRC) (Grant reference number NIHR203320). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. The funder has had no role in the design of this research.
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Copyright: © 2025 Bowhay B et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. How to cite: Bowhay B, Williams CA, Gibbons MA et al. Exploring the potential of cardiopulmonary exercise testing (CPET) for tailored pulmonary rehabilitation in people with interstitial lung disease (ILD): A systematic review protocol [version 2; peer review: 2 approved, 1 approved with reservations]. NIHR Open Res 2025, 4:51 (https://doi.org/10.3310/nihropenres.13706.2) First published: 17 Sep 2024, 4:51 (https://doi.org/10.3310/nihropenres.13706.1) Latest published: 04 Jul 2025, 4:51 (https://doi.org/10.3310/nihropenres.13706.2) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
This protocol has been updated following review. Reviewer #1 has endorsed the manuscript in its current form, yet had valuable commentary which we have incorporated into the updated version. Reviewer #2 provisionally endorsed this version, and we have incorporated further changes in light of their comments.
This protocol has been updated following review. Reviewer #1 has endorsed the manuscript in its current form, yet had valuable commentary which we have incorporated into the updated version. Reviewer #2 provisionally endorsed this version, and we have incorporated further changes in light of their comments.
To read any peer review reports and author responses for this article, follow the "read" links in the Open Peer Review table.
Interstitial lung disease (ILD) is a heterogeneous group of approximately 200 chronic lung conditions, which are associated with lung parenchymal fibrosis and/or interstitial inflammation1. Consequently, respiratory failure is the primary cause of mortality in people with ILD2. According to 2017 figures, the median age-standardised incidence rates (ASIR) of ILD in United Kingdom (UK) men was 10.92 per 100,000, and 6.7 per 100,000 for UK women3. From the period between 2001 and 2017, the ASIR has risen by 21.27% for UK men and 25.39% for UK women3. In addition, the median age-standardised death rates indicated that ILD related mortality was 2.04 (IQR 1.13–2.71) per 100 000 population for men and 1.02 (0.68–1.37) per 100,000 population for women3. Unfortunately, ILD are chronic conditions that cannot be cured, therefore maintaining lung function, general function, and quality of life (QoL) of people with ILD (pwILD) is a key focus for patients and clinicians alike4.
A joint statement produced by the American Thoracic Society (ATS) and European Respiratory Society (ERS) recommends regular exercise training and pulmonary rehabilitation (PR) to enhance cardiorespiratory health5, whereby exercise is acknowledged as a planned, structured, and repetitive form of physical activity which is performed for the improvement or maintenance of physical fitness6. International guidelines highlight that exercise training is regarded as a cornerstone of PR5. However, individual patient responses to exercise training are highly variable and a ‘one size fits all’ training approach does not benefit every pwILD7, thus placing the onus on to effective PR design.
Pulmonary rehabilitation is an intervention which is developed following comprehensive diagnostic evaluation by a multidisciplinary team; the aim is to utilise these assessment outcomes to establish a patient-centred therapeutic program which consists of exercise and patient education to support behaviour change, but also improve physical and mental health for people with chronic respiratory diseases8. The British Thoracic Society (BTS) explicitly recommends that PR should be offered to symptomatic individuals with chronic respiratory disease, including pwILD8. Therefore, National Health Service in the United Kingdom, alongside the National Respiratory Audit Programme (NRAP) are aiming to drive forward the quality of PR services9.
A 2021 Cochrane review of PR in pwILD has found “moderate-certainty” evidence associated with enhanced functional exercise capacity (measured by the six-minute walk test, 6MWT) and “low-certainty” evidence that suggests that PR in pwILD may improve maximum exercise capacity (WRpeak) and dyspnoea10. These benefits are postulated to be sustained in the longer term (e.g. 12 months duration) and there is also no evidence that adverse events were found in the pwILD11. Therefore, PR is not only useful for enhancing QoL in pwILD, but functional capacity as well11. However, no PR guidelines have been developed specifically for pwILD at present, despite them being available for other chronic respiratory diseases such as COPD12. Therefore, the James Lind Alliance has made ‘best exercise program for people with Pulmonary Fibrosis’ part of their top ten research priorities13.
The main challenge for development of PR guidelines in ILD is related to the breath of pathophysiological impairments that occur across the different ILD subgroups, which may lead to variation in exercise tolerance and capacity14. Restrictions in exercise tolerance may be due to ventilation/perfusion (V/Q) mismatch, which occurs when either airflow or blood flow in the lungs is impaired and abnormal ventilatory mechanics can occur at different points for pwILD14. Therefore, pwILD may often require more ventilatory load and capacity to sustain exercise, whilst also attempting to combat muscle fatigue, commonly because of poor blood oxygenation14; this may lower ATP, increase lactate and cause a rise in VCO211. Gas exchange insufficiency, central haemodynamic impairment and muscle deconditioning are prevalent in the ILD population14. Therefore a tailored approach to exercise prescription may provide enhanced physical function outcomes, as tailoring could account for these mechanisms of exercise intolerance in chronic lung diseases15. However, due to the complex characteristics of ILD, a review of the methods used for tailored exercise prescription is required, before comprehensive guidelines in this population can be developed.
The BTS Clinical Statement on pulmonary rehabilitation states that a validated exercise test should be conducted as a core component of PR programmes to inform tailored prescription8. Within ILD management, field tests such as 6-minute walk distance (6MWD)16–18 and the incremental shuttle walk test (ISWT)19 are often used as a functional outcome because they are valid, easy to implement and cost-effective16–19. However, field tests cannot highlight the full spectrum of pathophysiological mechanisms which limit exercise tolerance, and safety issues such as ischemia or arrhythmias cannot be easily detected20. Both aspects are of upmost importance when looking to prescribe exercise in the ILD population, due to the aforementioned physiological impairments14. Therefore, the focus of this systematic review is to explore the potential utility of CPET to provide the precision required for tailored exercise prescription in ILD.
Tailored exercise via CPET has been earmarked as the future of PR, whereby a comprehensive evaluation of pathophysiological systems serves to indicate responses to exercise, and therefore these values could support effective PR programming14. Evidence suggests that CPET is now the gold standard for the causal evaluation of exercise intolerance in patients with long term pulmonary conditions21. It has been demonstrated that CPET is a safe and valuable method for the comprehensive evaluation of cardiac, pulmonary and muscle function21, whilst also recognising physiological factors limiting exercise such as dyspnoea22.
Exercise prescription methods which are tailored to the cardiovascular, pulmonary, and peripheral muscle metabolic limitations of the individual patient have the potential to be the cornerstone of tailored PR14. Recent evidence suggests that tailored, moderate-intensity continuous aerobic exercise (at 60% maximum heart rate; HRmax) and high-intensity interval training (at 80% HRmax) is beneficial in pwILD for improving WRpeak and dysponea23. Moreover, tailored exercise training can enhance antioxidant buffering capacity in people with idiopathic pulmonary fibrosis (IPF), which may corelate with enhanced muscle fatigue resilience24. This clearly demonstrates the functional and physiological value PR can have when using tailored approaches.
However, for widespread success of tailored PR programmes in ILD, implementation of exercise prescription principles (e.g. specificity, frequency, intensity, timing, type, overload, progression, adaptation, and reversibility) should be followed and reported accordingly5. At present, it is not clear if this is currently done for pwILD; the current systematic review helps provide an overview of practice regarding the components of exercise prescription in this population.
There is also a need to develop a valid, reliable, and consistent method for personalising PR based on CPET outcome measures. Several metrics could be used (e.g. VO2peak or heart rate), but it is unclear what metrics are currently used and how they are implemented. This systematic review will seek to address this, with the intention of highlighting the CPET-derived exercise prescription variables that have been used to tailor PR for pwILD.
The PRISMA-P has been used to guide this systematic review protocol25. Eligibility for inclusion in this review include the following elements of the PICOS framework (Table 1); conference abstracts will be excluded; articles which are not published in English, unless an English translation is available, will be excluded; there will be no restriction on publication date, or location.
Population
People of all ages, sexes and ethnic groups that have been diagnosed with any ILD subtype.
Intervention
Tailored PR or exercise programmes, which have used CPET derived values. Articles that only describe ‘physical activity’ interventions, and not ‘exercise training’ or ‘pulmonary rehabilitation’, will be excluded. Single or acute bouts of exercise will not classify as exercise training.
Comparison
Outcomes of PR regimens against group baselines, and where possible, against control groups as well will be compared.
Outcomes
Outcomes will be derived from CPET values. It is anticipated this may include, but will not be limited to:
a) Peak volume of oxygen consumption (VO2peak), the gold-standard measure of cardiorespiratory fitness, expressed as mL.kg-1.min-1 or L.min-1;
b) Peak work rate (WRpeak), expressed in watts (W), the maximum achieved work rate during an incremental CPET;
c) Volume of oxygen consumption at anaerobic threshold (VO2-AT) expressed as mL.kg-1.min-1, L.min-1, or %VO2peak;
d) Rate of perceived exertion (RPE) that can be measured on a 0–10 RPE scale or a Borg 6–20 scale.
e) Rate of perceived exertion (RPE) that can be measured on a 0–10 RPE scale or a Borg 6–20 scale.
Study designs
All quantitative study designs will be included; for instance, RCT’s, single cohort studies and case studies. Only full-text, original articles will be included.
Electronic searches will be conducted using Ovid® (Ovid Technologies Inc., New York, NY, USA), incorporating Ovid MEDLINE® (US National Library of Medicine, Bethesda, MD, USA), Ovid EmbaseTM (Elsevier Inc., Philadelphia, PA, USA), EBSCO databases CINAHL Ultimate and SPORTDiscus (EBSCO Information Services, MA, USA) plus CENTRAL and the Cochrane Library (John Wiley and Sons Ltd, Hoboken, NJ, USA) will all be searched up to January 2025.
The search strategy is available at OSFHOME: Exploring the potential of cardiopulmonary exercise testing (CPET) for individualised pulmonary rehabilitation in people with interstitial lung disease (ILD): A systematic review protocol: Search_Strategy.docx. Available at: https://doi.org/10.17605/OSF.IO/43N29.
Following completion of the Ovid MEDLINE® strategy, specific syntax and subject headings will be created for all Ovid, EBSCO and Cochrane database searches.
Independent data extraction will take place using data extraction forms developed for the study. Data to be extracted and included in the table of ‘overview of included studies’ will include author and year, purpose of study, setting, country, sample size, participant demographic and clinical diagnosis, treatment types, study design, primary outcome measures, losses and exclusion of participants. EndNote© 2026 (Clarivate, London, UK) will be utilised for reference storage.
A screen of the initial search results will be performed by title and abstract for eligibility and inclusion. The search results will be checked by a single reviewer (BB), then an experienced second reviewer (TBC) will perform a check of 10%, then a third reviewer (TBC) will check for differences and achieve a consensus through discussion with the reviewers.
Data will be collected by a single reviewer (BB) using a data extraction form. A random double data extraction (10%) check will then be performed by a second reviewer (TBC). Any differences will be highlighted by a third reviewer (TBC), then a discussion with the reviewers will be performed to achieve a consensus. Any missing data will be requested from the study authors, before removal from the review, if no reply is provided.
The PICOS inclusion and exclusion criteria (Table 1) will be used by (BB and TBC) to as a framework to collate and review all the full text articles which are potentially relevant for the review. If disagreement occurs between the reviewers, then a discussion with the third reviewer (TBC) will be conducted to reach consensus. Outcomes will be derived from CPET values. We anticipate that the main outcomes will be displayed in a summary of findings table using GRADEpro27.
Quality assessment of the included studies will be performed by two reviewers (BB; TBC) using the Critical Appraisal Skills Program (CASP) checklists for single cohort studies28 and randomised controlled studies29, thus accounting for the anticipated variances in study designs for this review. A third reviewer (TBC) would then confirm the results and lead the discussion towards consensus of the included studies. The CASP checklist items are to be marked “Y” (Yes) if well described, “N” (No) if inadequate, and unclear items with a “U” (Unclear).
Reporting quality
The Consensus on Exercise Reporting Template (CERT) assessment form will be used to check the reporting of exercise programme domains30. This would support researchers to develop effective exercise interventions, that are well constructed and reproduceable. Using the CERT would also help policymakers with making exercise recommendations and guide peer reviewers in manuscripts evaluation30.
All analyses will be performed using Review Manager31.
a. Data pertaining to variables used to prescribe, and how, will be narratively discussed and analysed using frequency statistics.
b. Where possible, analyses of between groups to receive tailored PR against controls will be undertaken. If no mean change and standard deviation of change are reported, then a corresponding author data request will be made. If no data or response is gained, then results will be calculated using methods in the Cochrane Handbook32. The summary effect size is estimated by using mean difference (MD) with 95% CI for continuous outcomes.
Standardized mean differences (SMD) will be utilised instead, if different methods or scales are used for the outcome. Heterogeneity will be estimated from the MD and SMD via a χ2 test. In addition, the I2 test will also be utilised to add extra analysis. Signifficant heterogeneity will be reached at P50% in the I2 test. A random-effect or fixed-effect model will be selected to merge the outcomes.
Meta-bias(es)
Reporting bias would be explored by examining if the protocol was published prior to study participant recruitment. A Clinical Trial Register at the International Clinical Trials Registry Platform of the World Health Organisation screen would also be conducted. Selective outcome reporting bias would be evaluated by comparing the fixed effect estimate against the random effects model to examine the potential for sample bias. If this occurs, then a random effects estimate would be advantageous, when compared against a fixed effect estimate. Reporting bias could also be examined by funnel plots if ≥10 studies are identified.
The current systematic review has been developed to explore how CPET-derived outcomes can help support tailored PR design for pwILD. At present, there are no systematic reviews that provide insights into how CPET values can be utilised for tailored exercise and PR programming in pwILD.
The most relevant databases have been selected specifically for this systematic review, and in addition, all study designs have been included, which although a strength of this systematic review, may add complexity when looking to interpret the results across the board. Thus, due to the potential variability in both the condition subgroups within ILD and how PR interventions may be designed, it is possible that separate analyses may be required.
A potential limitation of this study would be the focus on CPET, without direct comparison against field tests. The potential strength of this review is that exploring CPET, as a tool for tailoring exercise, may help to indicate beneficial methods for PR prescription in the ILD population. The overall aim following this review is to develop a valid, reliable, and consistent method for tailoring PR based on CPET outcome measures to address the current evidence gap. Several metrics may be used (e.g. VO2peak, heart rate), but it is unclear how and why they are utilised in clinical practice for pwILD; therefore, this systematic review aims to fill this research gap.
Interstitial Lung Diseases; Pulmonary Rehabilitation; Exercise; CPET; Treatment Outcomes; Training; Physiotherapy; Systematic Review.
CPET: Cardiopulmonary Exercise Testing
ILD: Interstitial Lung disease
UK: United Kingdom
PR: Pulmonary Rehabilitation
VO2peak: Peak volume of oxygen consumption
WRpeak: Peak work rate
VO2-AT: Volume of oxygen consumption at anaerobic threshold
RER: Respiratory exchange ratio
VE: Minute ventilation
AT: Anaerobic Threshold
HR: Heart Rate
RPE: Rating of perceived exertion
ATS: American Thoracic Society
ERS: European Respiratory Society
BTS: British Thoracic Society
pwILD: people with interstitial lung disease
CASP: Critical Appraisal Skills Program
GRADE: Grading of Recommendations, Assessment, Development, and Evaluations
HRR: Heart Rate Reserve
COPD: Chronic Obstructive Pulmonary Disease
HFA-PEFF: The Heart Failure Association (HFA)-PEFF score
6MWT: Six-minute walk test
6MWD: Six-minute walk distance
ICT: Incremental cycle test
RCT: Randomised controlled trial
In the event of protocol amendments, the date of each amendment will be accompanied by a description of the change and the rationale.
Not applicable
Not applicable
Reporting guidelines are available at OSFHOME: Exploring the potential of cardiopulmonary exercise testing (CPET) for individualised pulmonary rehabilitation in people with interstitial lung disease (ILD): A systematic review protocol: PRISMA-P.doc.x. Available at: https://doi.org/10.17605/OSF.IO/43N2925.
Data is available under Creative Commons Zero (CC0): 1.0 Universal.
OSFHOME: Exploring the potential of cardiopulmonary exercise testing (CPET) for individualised pulmonary rehabilitation in people with interstitial lung disease (ILD): A systematic review protocol
Available at: https://doi.org/10.17605/OSF.IO/43N2925
This project contains:
Inclusion and exclusion criteria - Protocol.docx
Search_Strategy.docx
Data is available under Creative Commons Zero (CC0): 1.0 Universal.
Conceptualisation: CW, MG, CS, OT; Design: BB, OT; Drafting Manuscript: BB; Critical Review of Manuscript: BB, CW, MG, CS, OT; Agreement ot be Accountable: BB, CW, MG, CS, OT.
Our team would like to acknowledge the NIHR ARC South West Peninsula (PenARC) department who supported us in the search strategy design.
Faculty Opinions recommendedReferences
- 1. Saketkoo LA, Escorpizo R, Varga J, et al.: World Health Organization (WHO) International Classification of Functioning, Disability and Health (ICF) core set development for Interstitial Lung Disease. Front Pharmacol. 2022; 13: 979788. PubMed Abstract | Publisher Full Text | Free Full Text
- 2. Rosato E, Leodori G, Gigante A, et al.: Reduced ventilatory efficiency during exercise predicts major vascular complications and mortality for Interstitial Lung Disease in systemic sclerosis. Clin Exp Rheumatol. 2020; 38 Suppl 125(3): S85–S91. PubMed Abstract
- 3. Salciccioli JD, Marshall DC, Goodall R, et al.: Interstitial Lung Disease incidence and mortality in the UK and the European Union: an observational study, 2001-2017. ERJ Open Res. 2022; 8(3): 00058–2022. PubMed Abstract | Publisher Full Text | Free Full Text
- 4. Nakazawa A, Cox NS, Holland AE: Current best practice in rehabilitation in Interstitial Lung Disease. Ther Adv Respir Dis. 2017; 11(2): 115–128. PubMed Abstract | Publisher Full Text | Free Full Text
- 5. Spruit MA, Singh SJ, Garvey C, et al.: An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in Pulmonary Rehabilitation. Am J Respir Crit Care Med. 2013; 188(8): e13–e64. PubMed Abstract | Publisher Full Text
- 6. Gloeckl R, Schneeberger T, Jarosch I, et al.: Pulmonary Rehabilitation and exercise training in Chronic Obstructive Pulmonary Disease. Dtsch Arztebl Int. 2018; 115(8): 117–123. PubMed Abstract | Publisher Full Text | Free Full Text
- 7. Cox NS, Holland AE: Pulmonary rehabilitation: one size does not fit all. Thorax. 2025; 80(4): 189–190. PubMed Abstract | Publisher Full Text
- 8. Man W, Chaplin E, Daynes E, et al.: British Thoracic Society clinical statement on Pulmonary Rehabilitation. Thorax. 2023; 78(Suppl 4): s2–s15. PubMed Abstract | Publisher Full Text
- 9. Royal College of Physicians: National Respiratory Audit Programme: organisational audit 2024. Resourcing and organisation of asthma and COPD care in hospitals, and PR services in England and Wales. Summary report. RCP, 2024. Reference Source
- 10. Dowman L, Hill CJ, May A, et al.: Pulmonary Rehabilitation for Interstitial Lung Disease. Cochrane Database Syst Rev. 2021; 2(2): CD006322. PubMed Abstract | Publisher Full Text | Free Full Text
- 11. Wickerson L, Brooks D, Granton J, et al.: Interval aerobic exercise in individuals with advanced Interstitial Lung Disease: a feasibility study. Physiother Theory Pract. 2021; 37(9): 1034–1042. PubMed Abstract | Publisher Full Text
- 12. National Institute for Health and Care Excellence (NICE): Chronic obstructive pulmonary disease in adults. 2011; (updated 2023). Reference Source
- 13. Tikellis G, Tong A, Lee JYT, et al.: Top 10 research priorities for people living with pulmonary fibrosis, their caregivers, healthcare professionals and researchers. Thorax. 2021; 76(6): 575–581. PubMed Abstract | Publisher Full Text
- 14. Bonini M, Fiorenzano G: Exertional dyspnoea in Interstitial Lung Diseases: the clinical utility of Cardiopulmonary Exercise Testing. Eur Respir Rev. 2017; 26(143): 160099. PubMed Abstract | Publisher Full Text | Free Full Text
- 15. Armstrong M, Vogiatzis I: Personalized exercise training in chronic lung diseases. Respirology. 2019; 24(9): 854–862. PubMed Abstract | Publisher Full Text
- 16. Holland AE, Dowman L, Fiore J, et al.: Cardiorespiratory responses to 6-Minute Walk Test in Interstitial Lung Disease: not always a submaximal test. BMC Pulm Med. 2014; 14: 136. PubMed Abstract | Publisher Full Text | Free Full Text
- 17. Nakazawa A, Dowman LM, Cox NS, et al.: Prescribing walking training in Interstitial Lung Disease from the 6-Minute Walk Test. Physiother Theory Pract. 2023; 39(4): 873–877. PubMed Abstract | Publisher Full Text
- 18. Rasekaba T, Lee AL, Naughton MT, et al.: The six-Minute Walk Test: a useful metric for the cardiopulmonary patient. Intern Med J. 2009; 39(8): 495–501. PubMed Abstract | Publisher Full Text
- 19. Silva Queiroz D, Marques da Silva CCB, Franco Amaral A, et al.: Evaluation of maximal exercise capacity through the Incremental Shuttle Walking Test in lymphangioleiomyomatosis. Pulmonology. 2024; 30(6): 563–569. PubMed Abstract | Publisher Full Text
- 20. ERS Task Force, Palange P, Ward SA, et al.: Recommendations on the use of exercise testing in clinical practice. Eur Respir J. 2007; 29(1): 185–209. PubMed Abstract | Publisher Full Text
- 21. Molgat-Seon Y, Schaeffer MR, Ryerson CJ, et al.: Cardiopulmonary Exercise Testing in patients with Interstitial Lung Disease. Front Physiol. 2020; 11: 832. PubMed Abstract | Publisher Full Text | Free Full Text
- 22. Radtke T, Crook S, Kaltsakas G, et al.: ERS statement on standardisation of Cardiopulmonary Exercise Testing in chronic lung diseases. Eur Respir Rev. 2019; 28(154): 180101. PubMed Abstract | Publisher Full Text | Free Full Text
- 23. Nikoletou D, Chis Ster I, Lech CY, et al.: Comparison of high-intensity interval training versus moderate-intensity continuous training in Pulmonary Rehabilitation for Interstitial Lung Disease: a randomised controlled pilot feasibility trial. BMJ Open. 2023; 13(8): e066609. PubMed Abstract | Publisher Full Text | Free Full Text
- 24. Wallis TJM, Minnion M, Freeman A, et al.: Individualised exercise training enhances antioxidant buffering capacity in Idiopathic Pulmonary Fibrosis. Antioxidants (Basel). 2023; 12(8): 1645. PubMed Abstract | Publisher Full Text | Free Full Text
- 25. Shamseer L, Moher D, Clarke M, et al.: Preferred Reporting Items for Systematic review and Meta-analysis Protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015; 350: g7647. PubMed Abstract | Publisher Full Text
- 26. The EndNote Team: EndNote. EndNote downloads. 2024; [cited 2024 Aug 14]. Reference Source
- 27. GRADEpro GDT. Cochrane. 2024; [cited 2024 Aug 14]. Reference Source
- 28. Critical Appraisal Skills Programme (CASP) Cohort Study Checklist. Critical Appraisal Skills Programme (CASP), 2018; [cited 2024 Aug 14]. Reference Source
- 29. Critical Appraisal Skills Programme (CASP) RCT Checklist. Critical Appraisal Skills Programme (CASP), 2020; [cited 2024 Aug 14]. Reference Source
- 30. Slade SC, Dionne CE, Underwood M, et al.: Consensus on Exercise Reporting Template (CERT): explanation and elaboration statement. Br J Sports Med. 2016; 50(23): 1428–1437. PubMed Abstract | Publisher Full Text
- 31. Cochrane: Revman. RevMan | Cochrane Training. 2024; [cited 2024 Aug 14]. Reference Source
- 32. Cochrane Handbook for Systematic Reviews of interventions. Cochrane Handbook for Systematic Reviews of Interventions | Cochrane Training, 2023; [cited 2024 Aug 14]. Reference Source
- 33. GRADE handbook. GRADEpro, 2021; [cited 2024 Aug 14]. Reference Source
Version 2
VERSION 2 PUBLISHED 04 Jul 2025
Revised
Version 1
VERSION 1 PUBLISHED 17 Sep 2024